Shares of China Cord Blood Corp. (NYSE:CO) saw unusually-high trading volume on Friday . Approximately 77,832 shares were traded during mid-day trading, an increase of 47% from the previous session’s volume of 52,954 shares.The stock last traded at $5.46 and had previously closed at $5.55.

Separately, Zacks Investment Research cut China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research report on Monday, March 21st. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $8.33.

The stock’s 50 day moving average price is $5.89 and its 200-day moving average price is $6.03. The stock has a market cap of $399.33 million and a price-to-earnings ratio of 29.25.

China Cord Blood Corp. (NYSE:CO) last posted its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.03. The firm had revenue of $24.30 million for the quarter. On average, equities analysts predict that China Cord Blood Corp. will post $0.17 EPS for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.